Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Disposable Infusion Extension Lines market in this environment.
In terms of revenue, this research report indicated that the global Disposable Infusion Extension Lines market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Disposable Infusion Extension Lines industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Sarstedt aims at producing XX K Units Disposable Infusion Extension Lines in 2020, with XX % production to take place in global market, Bicakcilar accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Disposable Infusion Extension Lines Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Disposable Infusion Extension Lines Market
Sarstedt
Bicakcilar
Bionic Medizintechnik
Rontis
Fresenius Kabi
Vygon (UK)
Perfect Medical
Goldwin Medicare Ltd
George Philips
Polymed Medical Devices
EffeEmme
SPM Medicare Pvt. Ltd
Ningbo Greatcare Meditech
...
Major Type of Disposable Infusion Extension Lines Covered in Prudent Markets report:
Spiral-Line
Small Bore Connection Tubing
Other
Application Segments Covered in Prudent Markets Market
Hospitals
Clinics
Ambulatory Surgical Centers
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Disposable Infusion Extension Lines Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Spiral-Line -Product Introduction and Major Manufacturers
1.1.2 Small Bore Connection Tubing -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Disposable Infusion Extension Lines Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Disposable Infusion Extension Lines Market
3.1.1 Top Companies leading Disposable Infusion Extension Lines Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Disposable Infusion Extension Lines Market
3.2.1 Top Companies leading Disposable Infusion Extension Lines Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Disposable Infusion Extension Lines Market
3.3.1 Top Companies leading Disposable Infusion Extension Lines Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Disposable Infusion Extension Lines Market
3.4.1 Top Companies leading Disposable Infusion Extension Lines Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Disposable Infusion Extension Lines Market
3.5.1 Top Companies leading Disposable Infusion Extension Lines Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Disposable Infusion Extension Lines Market
3.6.1 Top Companies leading Disposable Infusion Extension Lines Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Disposable Infusion Extension Lines Market
3.7.1 Top Companies leading Disposable Infusion Extension Lines Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Disposable Infusion Extension Lines Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Disposable Infusion Extension Lines Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Disposable Infusion Extension Lines Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Disposable Infusion Extension Lines Sales and Growth Rate (2021-2027)
5.2 Global Disposable Infusion Extension Lines Sales Value and Growth Rate (2021-2027)
6 Disposable Infusion Extension Lines Competitive Analysis
6.1 Sarstedt
6.1.1 Sarstedt Company Profiles
6.1.2 Sarstedt Product Introduction
6.1.3 Sarstedt Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Bicakcilar
6.2.1 Bicakcilar Company Profiles
6.2.2 Bicakcilar Product Introduction
6.2.3 Bicakcilar Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Bionic Medizintechnik
6.3.1 Bionic Medizintechnik Company Profiles
6.3.2 Bionic Medizintechnik Product Introduction
6.3.3 Bionic Medizintechnik Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Rontis
6.4.1 Rontis Company Profiles
6.4.2 Rontis Product Introduction
6.4.3 Rontis Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Company Profiles
6.5.2 Fresenius Kabi Product Introduction
6.5.3 Fresenius Kabi Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Vygon (UK)
6.6.1 Vygon (UK) Company Profiles
6.6.2 Vygon (UK) Product Introduction
6.6.3 Vygon (UK) Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Perfect Medical
6.7.1 Perfect Medical Company Profiles
6.7.2 Perfect Medical Product Introduction
6.7.3 Perfect Medical Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Goldwin Medicare Ltd
6.8.1 Goldwin Medicare Ltd Company Profiles
6.8.2 Goldwin Medicare Ltd Product Introduction
6.8.3 Goldwin Medicare Ltd Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 George Philips
6.9.1 George Philips Company Profiles
6.9.2 George Philips Product Introduction
6.9.3 George Philips Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Polymed Medical Devices
6.10.1 Polymed Medical Devices Company Profiles
6.10.2 Polymed Medical Devices Product Introduction
6.10.3 Polymed Medical Devices Disposable Infusion Extension Lines Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 EffeEmme
6.12 SPM Medicare Pvt. Ltd
6.13 Ningbo Greatcare Meditech
7 Conclusion